Lovelace biomedical research institute(CHEM) - IDIQ for barda CRN animal model development

Ended Indefinite Delivery Contract Awarded Last action

Contract number
75A50122D00008
Awardee
Awarding agency
Task orders
0

Award facts

Opportunity
Last date to order 100% complete
IDV ceiling
$45,000,000.00
Maximum order
$45,000,000.00
Award type
Single award
Who can order
Only the awarding agency
Set-aside
No set-aside
Competition
Full and Open Competition · 5 offers Negotiated Proposal / Quote
Pricing
Cost Plus Fixed Fee
Legislative mandates

Award details come from SAM.gov/FPDS.

About this IDV

This Indefinite Delivery/Indefinite Quantity contract, awarded as a single award to Lovelace Biomedical Research Institute on July 28, 2022, supports the Biomedical Advanced Research and Development Authority's Chemical Readiness and Response Network animal model development program. The Office of the Assistant Secretary for Preparedness and Response, within the Department of Health and Human Services, established this civilian contract with a ceiling value of $45,000,000 and a completion date of July 31, 2026. The contract procures nonclinical laboratory services and animal model development capabilities to evaluate medical countermeasures against chemical threats. Lovelace, a not-for-profit preclinical contract research organization based in Albuquerque, New Mexico, was selected to provide comprehensive capabilities in controlled exposure studies of animal species to chemical agents, disease model development, and associated preclinical testing services.

The original solicitation, posted January 25, 2021, sought multiple awards from laboratories qualified under either Group A (pulmonary threats and other chemical agents) or Group B (nerve and blister agents) classifications. Contractors were required to demonstrate proficiency through recent Good Laboratory Practice studies and capability to work with Schedule 1 chemical threat agents where applicable. Task orders issued under this Indefinite Delivery/Indefinite Quantity contract define the specific scope, methodology, and budget for individual studies and evaluations. Lovelace's selection reflects its extensive federal research portfolio, including prior work with the National Institute of Allergy and Infectious Diseases, National Center for Advancing Translational Sciences, and the Office of the Assistant Secretary for Preparedness and Response, positioning the organization to deliver sophisticated preclinical research and medical countermeasure development services essential to national preparedness and response capabilities.

Transactions

Action Obligated Date
Exercise an Option P00008 $0
Other Administrative Action P00007 $0
Exercise an Option P00006 $0
Other Administrative Action P00005 $0
Other Administrative Action P00004 $0
Exercise an Option P00003 $0
Other Administrative Action P00002 $0
Other Administrative Action P00001 $0
Original award $75,000

Quick answers

Who was awarded contract 75A50122D00008?

75A50122D00008 was awarded to Lovelace Biomedical Research Institute by Office of the Assistant Secretary for Preparedness and Response (Department of Health and Human Services) on July 28, 2022.

How much is contract 75A50122D00008 worth?

75A50122D00008's own ceiling is $45,000,000. A single order can be worth up to $45,000,000.

Who can order from contract 75A50122D00008?

75A50122D00008 is a single award indefinite delivery contract. Only the awarding agency can place orders on it.

Was contract 75A50122D00008 competed?

The extent of competition for 75A50122D00008 was full and open competition. The government received 5 offers.

On GovTribe

See this IDV's full record

  • Every order and transaction
  • The awardee's other awards and teaming partners
  • Similar IDVs and recompete opportunities
  • Ask GovTribe AI about this IDV